Title : Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53.

Pub. Date : 2016 May

PMID : 26596838






9 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53. Aspirin tumor protein p53 Homo sapiens
2 Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53. Aspirin tumor protein p53 Homo sapiens
3 Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53. Aspirin tumor protein p53 Homo sapiens
4 We previously demonstrated that aspirin acetylated the tumor suppressor protein p53 at lysine 382 in MDA-MB-231 human breast cancer cells. Aspirin tumor protein p53 Homo sapiens
5 We demonstrate that aspirin induced acetylation of p53 in both cell lines in a concentration-dependent manner. Aspirin tumor protein p53 Homo sapiens
6 Aspirin-acetylated p53 was localized to the nucleus. Aspirin tumor protein p53 Homo sapiens
7 Aspirin also acetylated recombinant p53 (rp53) in vitro suggesting that it occurs through a non-enzymatic chemical reaction. Aspirin tumor protein p53 Homo sapiens
8 Our results suggest that aspirin"s anti-cancer effect may involve acetylation and activation of wild type and mutant p53 and induction of target gene expression. Aspirin tumor protein p53 Homo sapiens
9 This is the first report attempting to characterize p53 acetylation sites targeted by aspirin. Aspirin tumor protein p53 Homo sapiens